-- New brand reflects commitment to Science, Results, Trust

Syneron-Candela, a leading global medical aesthetic device company, announced 
today that it has rebranded the company to Candela and will be unveiling new 
corporate branding at the American Academy of Dermatology (AAD) Annual Meeting 
in Washington D.C, between March 1-5, 2019. The new corporate identity reflects 
the unification of the Syneron and Candela brands and is designed to support 
continued global market growth as a unified single entity.

Logo - https://mma.prnewswire.com/media/827799/Candela_Logo.jpg 

Established in 1970, Candela, has a long history of technological innovation 
bringing to market best in class medical aesthetic energy-based devices. 
"Re-launching the company as Candela and aligning around its brand pillars of 
Science, Results and Trust, reflects our commitment to Candela's guiding 
principles of safety, efficacy and reliability. It also reflects our commitment 
to strengthening the longstanding partnerships of trust Candela has established 
with physicians, their practices and the patients they treat," says Geoffrey 
Crouse, Chief Executive Officer of Candela. Candela's new brand identity will 
go live today with the launch of its new corporate website 
www.candelamedical.com, new marketing materials, print, digital and social 
campaigns. New patient, physician and practice focused assets will continue to 
be rolled out over the course of the year.

"Scientific rigor, clinical outcomes and building trusting partnerships with 
physicians are the same values that established Candela's historic leadership 
over the years. The combination of Candela's new management, innovation of 
products such as the Vbeam Prima system coupled with Candela's values, strongly 
positions the company for continued growth while making them an even more 
trusted partner to medical aesthetic practices globally," says Eric Bernstein, 
MD, an Ardmore, Pennsylvania based dermatologist who is also chairperson of 
Candela's Medical Advisory Board. 

In addition to unveiling its new visual brand identity, Candela's products and 
technologies highlighting clinical outcomes will be presented during 18 
clinical presentations and educational courses at the AAD. Candela will also be 
showcasing its newest products–the Vbeam(R) Prima and Nordlys systems. The 
Vbeam Prima device is an advanced 595 nm pulse dye laser (PDL). With the 
addition of a 1064 nm wavelength and a number of other new user focused 
features, the Vbeam Prima device is able to effectively treat a broad range of 
skin conditions, including: rosacea, port wine stains, acne, facial, leg and 
spider veins, scars, benign pigmented lesions and wrinkles, warts, stretch 
marks and photo aging.

The Nordlys device is a multi-application, multi-technology IPL and Nd:YAG 
platform for vascular and pigmented lesions, as well as hair removal. The 
Nordlys system also offers a fractionated 1550 nm handpiece for skin 
resurfacing.  Both devices as part of the entire portfolio of Candela products 
will be on display at the Candela exhibit (#2137) at the 2019 AAD.   For more 
information about the Vbeam Prima and Nordlys devices and the Candela 
portfolio, please visit www.candelamedical.com.

About Candela(R)
Candela is a leading US based global medical aesthetic device company with 
headquarters in Wayland, Massachusetts.  The company's technology enables 
physicians to provide advanced solutions for a broad range of medical-aesthetic 
applications including hair removal, wrinkle reduction, tattoo removal, women's 
health treatments, facial resurfacing, traumatic and surgical scar treatments, 
body contouring, improving the skin's appearance through the treatment of 
benign vascular and pigmented lesions, and the treatment of acne, leg veins and 
cellulite. Candela has a wide portfolio of trusted, leading products, including 
Vbeam(R), the Gentle Family(R), CO2RE(R), CO2RE Intima(R), Profound(R), elôs 
Plus(R), PicoWay(R), UltraShape(R), VelaShape(R), IPL and other laser-based 
platforms. Acquired by Apax Partners in July 2017, the Company has an expansive 
global footprint and markets, services and supports its products in 86 
countries. It has offices in the United States, Australia, Canada, China, 
France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Portugal, Spain and 
the United Kingdom and many international distributors.

Contact:
EvolveMKD 
+1-646-517-4220 
candela@evolvemkd.com

SOURCE  Candela